nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—PDE4A—chronic obstructive pulmonary disease	0.374	1	CbGaD
Amlexanox—PDE4C—Roflumilast—chronic obstructive pulmonary disease	0.149	0.274	CbGbCtD
Amlexanox—PDE4D—Roflumilast—chronic obstructive pulmonary disease	0.138	0.254	CbGbCtD
Amlexanox—PDE4A—Roflumilast—chronic obstructive pulmonary disease	0.102	0.188	CbGbCtD
Amlexanox—PDE4B—Roflumilast—chronic obstructive pulmonary disease	0.0975	0.18	CbGbCtD
Amlexanox—PDE4A—Aminophylline—chronic obstructive pulmonary disease	0.0561	0.103	CbGbCtD
Amlexanox—IL3—connective tissue—chronic obstructive pulmonary disease	0.00466	0.166	CbGeAlD
Amlexanox—S100A13—respiratory system—chronic obstructive pulmonary disease	0.00251	0.0896	CbGeAlD
Amlexanox—S100A12—respiratory system—chronic obstructive pulmonary disease	0.00248	0.0884	CbGeAlD
Amlexanox—S100A13—connective tissue—chronic obstructive pulmonary disease	0.00221	0.0789	CbGeAlD
Amlexanox—S100A12—connective tissue—chronic obstructive pulmonary disease	0.00218	0.0778	CbGeAlD
Amlexanox—S100A13—smooth muscle tissue—chronic obstructive pulmonary disease	0.00202	0.0721	CbGeAlD
Amlexanox—FGF1—respiratory system—chronic obstructive pulmonary disease	0.00155	0.0552	CbGeAlD
Amlexanox—FGF1—connective tissue—chronic obstructive pulmonary disease	0.00136	0.0486	CbGeAlD
Amlexanox—S100A13—lung—chronic obstructive pulmonary disease	0.00133	0.0476	CbGeAlD
Amlexanox—S100A12—lung—chronic obstructive pulmonary disease	0.00132	0.0469	CbGeAlD
Amlexanox—FGF1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00125	0.0444	CbGeAlD
Amlexanox—PDE4D—lung—chronic obstructive pulmonary disease	0.000878	0.0313	CbGeAlD
Amlexanox—PDE4B—respiratory system—chronic obstructive pulmonary disease	0.000873	0.0311	CbGeAlD
Amlexanox—FGF1—lung—chronic obstructive pulmonary disease	0.000821	0.0293	CbGeAlD
Amlexanox—PDE4A—lung—chronic obstructive pulmonary disease	0.000777	0.0277	CbGeAlD
Amlexanox—PDE4B—bronchus—chronic obstructive pulmonary disease	0.000718	0.0256	CbGeAlD
Amlexanox—PDE4B—trachea—chronic obstructive pulmonary disease	0.000645	0.023	CbGeAlD
Amlexanox—PDE4B—lung—chronic obstructive pulmonary disease	0.000463	0.0165	CbGeAlD
Amlexanox—Mouth ulceration—Tiotropium—chronic obstructive pulmonary disease	0.000258	0.078	CcSEcCtD
Amlexanox—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.000159	0.048	CcSEcCtD
Amlexanox—Stomatitis—Tiotropium—chronic obstructive pulmonary disease	0.000155	0.047	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00014	0.0423	CcSEcCtD
Amlexanox—Stomatitis—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.0359	CcSEcCtD
Amlexanox—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000106	0.032	CcSEcCtD
Amlexanox—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000101	0.0307	CcSEcCtD
Amlexanox—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	9.97e-05	0.0302	CcSEcCtD
Amlexanox—Nausea—Roflumilast—chronic obstructive pulmonary disease	9.6e-05	0.0291	CcSEcCtD
Amlexanox—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	9.13e-05	0.0276	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	8.78e-05	0.0266	CcSEcCtD
Amlexanox—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	8.04e-05	0.0244	CcSEcCtD
Amlexanox—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	8.04e-05	0.0244	CcSEcCtD
Amlexanox—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	7.88e-05	0.0239	CcSEcCtD
Amlexanox—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	7.6e-05	0.023	CcSEcCtD
Amlexanox—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	7.21e-05	0.0219	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	7.08e-05	0.0214	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	7.08e-05	0.0214	CcSEcCtD
Amlexanox—Pain—Formoterol—chronic obstructive pulmonary disease	7.01e-05	0.0212	CcSEcCtD
Amlexanox—Pain—Arformoterol—chronic obstructive pulmonary disease	7.01e-05	0.0212	CcSEcCtD
Amlexanox—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	6.96e-05	0.0211	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	6.94e-05	0.021	CcSEcCtD
Amlexanox—Pain—Montelukast—chronic obstructive pulmonary disease	6.87e-05	0.0208	CcSEcCtD
Amlexanox—Headache—Aminophylline—chronic obstructive pulmonary disease	6.75e-05	0.0204	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	6.69e-05	0.0203	CcSEcCtD
Amlexanox—Pain—Salbutamol—chronic obstructive pulmonary disease	6.62e-05	0.0201	CcSEcCtD
Amlexanox—Nausea—Aminophylline—chronic obstructive pulmonary disease	6.4e-05	0.0194	CcSEcCtD
Amlexanox—Headache—Tiotropium—chronic obstructive pulmonary disease	6.37e-05	0.0193	CcSEcCtD
Amlexanox—Nausea—Tiotropium—chronic obstructive pulmonary disease	6.04e-05	0.0183	CcSEcCtD
Amlexanox—PDE4D—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	5.15e-05	0.001	CbGpPWpGaD
Amlexanox—Headache—Formoterol—chronic obstructive pulmonary disease	5.14e-05	0.0156	CcSEcCtD
Amlexanox—Headache—Arformoterol—chronic obstructive pulmonary disease	5.14e-05	0.0156	CcSEcCtD
Amlexanox—FGF1—IGF1R signaling cascade—IL6—chronic obstructive pulmonary disease	5.08e-05	0.000989	CbGpPWpGaD
Amlexanox—FGF1—Insulin receptor signalling cascade—IL6—chronic obstructive pulmonary disease	5.08e-05	0.000989	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	5.07e-05	0.000989	CbGpPWpGaD
Amlexanox—S100A12—Immune System—TLR2—chronic obstructive pulmonary disease	5.06e-05	0.000986	CbGpPWpGaD
Amlexanox—Headache—Montelukast—chronic obstructive pulmonary disease	5.03e-05	0.0152	CcSEcCtD
Amlexanox—FGF1—Innate Immune System—TLR2—chronic obstructive pulmonary disease	4.96e-05	0.000967	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.91e-05	0.000956	CbGpPWpGaD
Amlexanox—Nausea—Arformoterol—chronic obstructive pulmonary disease	4.87e-05	0.0148	CcSEcCtD
Amlexanox—Nausea—Formoterol—chronic obstructive pulmonary disease	4.87e-05	0.0148	CcSEcCtD
Amlexanox—Headache—Salbutamol—chronic obstructive pulmonary disease	4.85e-05	0.0147	CcSEcCtD
Amlexanox—IL3—Immune System—CD8A—chronic obstructive pulmonary disease	4.78e-05	0.000932	CbGpPWpGaD
Amlexanox—Nausea—Montelukast—chronic obstructive pulmonary disease	4.77e-05	0.0145	CcSEcCtD
Amlexanox—S100A12—Immune System—KL—chronic obstructive pulmonary disease	4.76e-05	0.000927	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	4.69e-05	0.000915	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—EGFR—chronic obstructive pulmonary disease	4.69e-05	0.000915	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.69e-05	0.000913	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—KL—chronic obstructive pulmonary disease	4.67e-05	0.000909	CbGpPWpGaD
Amlexanox—Nausea—Salbutamol—chronic obstructive pulmonary disease	4.6e-05	0.0139	CcSEcCtD
Amlexanox—IL3—Cytokine Signaling in Immune system—IL6—chronic obstructive pulmonary disease	4.55e-05	0.000887	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.54e-05	0.000884	CbGpPWpGaD
Amlexanox—FGF1—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	4.49e-05	0.000875	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—EGFR—chronic obstructive pulmonary disease	4.49e-05	0.000875	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.49e-05	0.000874	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—KL—chronic obstructive pulmonary disease	4.48e-05	0.000873	CbGpPWpGaD
Amlexanox—IL3—Immune System—ERBB3—chronic obstructive pulmonary disease	4.45e-05	0.000867	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	4.42e-05	0.000861	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.23e-05	0.000825	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.23e-05	0.000824	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—EGFR—chronic obstructive pulmonary disease	4.22e-05	0.000823	CbGpPWpGaD
Amlexanox—FGF1—Signaling by Insulin receptor—IL6—chronic obstructive pulmonary disease	4.22e-05	0.000822	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—EGFR—chronic obstructive pulmonary disease	4.2e-05	0.000818	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—EGFR—chronic obstructive pulmonary disease	4.18e-05	0.000814	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—EGFR—chronic obstructive pulmonary disease	4.16e-05	0.00081	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.13e-05	0.000804	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—EGFR—chronic obstructive pulmonary disease	4.1e-05	0.000799	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—VEGFA—chronic obstructive pulmonary disease	4.1e-05	0.000798	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.09e-05	0.000797	CbGpPWpGaD
Amlexanox—PDE4D—Myometrial Relaxation and Contraction Pathways—IL6—chronic obstructive pulmonary disease	4.07e-05	0.000794	CbGpPWpGaD
Amlexanox—IL3—Immune System—CRP—chronic obstructive pulmonary disease	4.07e-05	0.000793	CbGpPWpGaD
Amlexanox—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	3.99e-05	0.0121	CcSEcCtD
Amlexanox—FGF1—DAP12 interactions—EGFR—chronic obstructive pulmonary disease	3.91e-05	0.000763	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—EGFR—chronic obstructive pulmonary disease	3.91e-05	0.000763	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—EGFR—chronic obstructive pulmonary disease	3.91e-05	0.000763	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.91e-05	0.000761	CbGpPWpGaD
Amlexanox—IL3—Immune System—TLR4—chronic obstructive pulmonary disease	3.9e-05	0.00076	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—EGFR—chronic obstructive pulmonary disease	3.88e-05	0.000756	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—EGFR—chronic obstructive pulmonary disease	3.84e-05	0.000749	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.84e-05	0.000748	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.84e-05	0.000748	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CD8A—chronic obstructive pulmonary disease	3.83e-05	0.000747	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—EGFR—chronic obstructive pulmonary disease	3.83e-05	0.000746	CbGpPWpGaD
Amlexanox—Pain—Prednisolone—chronic obstructive pulmonary disease	3.8e-05	0.0115	CcSEcCtD
Amlexanox—PDE4C—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.78e-05	0.000736	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—TGFB1—chronic obstructive pulmonary disease	3.76e-05	0.000733	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.76e-05	0.000732	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.68e-05	0.000717	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.68e-05	0.000717	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—EGFR—chronic obstructive pulmonary disease	3.62e-05	0.000706	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.62e-05	0.000705	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CD8A—chronic obstructive pulmonary disease	3.61e-05	0.000704	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—IL6—chronic obstructive pulmonary disease	3.61e-05	0.000703	CbGpPWpGaD
Amlexanox—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—chronic obstructive pulmonary disease	3.59e-05	0.000699	CbGpPWpGaD
Amlexanox—S100A12—Immune System—ERBB3—chronic obstructive pulmonary disease	3.57e-05	0.000695	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.54e-05	0.00069	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.51e-05	0.000683	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.5e-05	0.000683	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	3.5e-05	0.000682	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—EGFR—chronic obstructive pulmonary disease	3.47e-05	0.000675	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—IL6—chronic obstructive pulmonary disease	3.45e-05	0.000673	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.44e-05	0.00067	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.43e-05	0.000669	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	3.4e-05	0.000662	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—ERBB3—chronic obstructive pulmonary disease	3.36e-05	0.000655	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.34e-05	0.000651	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.31e-05	0.000644	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.29e-05	0.000641	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CRP—chronic obstructive pulmonary disease	3.26e-05	0.000635	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—IL6—chronic obstructive pulmonary disease	3.24e-05	0.000632	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.24e-05	0.000632	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—IL6—chronic obstructive pulmonary disease	3.23e-05	0.000629	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—IL6—chronic obstructive pulmonary disease	3.21e-05	0.000626	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.21e-05	0.000625	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CRP—chronic obstructive pulmonary disease	3.2e-05	0.000623	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—IL6—chronic obstructive pulmonary disease	3.2e-05	0.000623	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.19e-05	0.000621	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.18e-05	0.00062	CbGpPWpGaD
Amlexanox—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	3.17e-05	0.00959	CcSEcCtD
Amlexanox—IL3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.16e-05	0.000617	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.15e-05	0.000613	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.13e-05	0.00061	CbGpPWpGaD
Amlexanox—S100A12—Immune System—TLR4—chronic obstructive pulmonary disease	3.13e-05	0.000609	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—TP53—chronic obstructive pulmonary disease	3.1e-05	0.000603	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.09e-05	0.000602	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—TLR4—chronic obstructive pulmonary disease	3.07e-05	0.000598	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—IL6—chronic obstructive pulmonary disease	3.01e-05	0.000586	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—IL6—chronic obstructive pulmonary disease	3.01e-05	0.000586	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—IL6—chronic obstructive pulmonary disease	3.01e-05	0.000586	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3e-05	0.000585	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3e-05	0.000584	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.99e-05	0.000582	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—IL6—chronic obstructive pulmonary disease	2.98e-05	0.000581	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—IL6—chronic obstructive pulmonary disease	2.95e-05	0.000576	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.94e-05	0.000574	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—IL6—chronic obstructive pulmonary disease	2.94e-05	0.000573	CbGpPWpGaD
Amlexanox—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	2.9e-05	0.00878	CcSEcCtD
Amlexanox—PDE4B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.9e-05	0.000565	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.9e-05	0.000564	CbGpPWpGaD
Amlexanox—FGF1—Immune System—TLR2—chronic obstructive pulmonary disease	2.89e-05	0.000563	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.88e-05	0.000561	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.88e-05	0.00056	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.84e-05	0.000554	CbGpPWpGaD
Amlexanox—Headache—Prednisolone—chronic obstructive pulmonary disease	2.78e-05	0.00843	CcSEcCtD
Amlexanox—PDE4B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.77e-05	0.00054	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.77e-05	0.000539	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.74e-05	0.000534	CbGpPWpGaD
Amlexanox—FGF1—Immune System—KL—chronic obstructive pulmonary disease	2.72e-05	0.00053	CbGpPWpGaD
Amlexanox—FGF1—Disease—HDAC2—chronic obstructive pulmonary disease	2.7e-05	0.000526	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	2.67e-05	0.000519	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	2.66e-05	0.000519	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—EGFR—chronic obstructive pulmonary disease	2.66e-05	0.000518	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.64e-05	0.000515	CbGpPWpGaD
Amlexanox—Nausea—Prednisolone—chronic obstructive pulmonary disease	2.64e-05	0.00799	CcSEcCtD
Amlexanox—PDE4B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.63e-05	0.000513	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.61e-05	0.000509	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.59e-05	0.000504	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.57e-05	0.000501	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL1B—chronic obstructive pulmonary disease	2.54e-05	0.000494	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.54e-05	0.000494	CbGpPWpGaD
Amlexanox—FGF1—Disease—KL—chronic obstructive pulmonary disease	2.51e-05	0.000489	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.49e-05	0.000485	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.46e-05	0.000479	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.3e-05	0.000449	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.3e-05	0.000449	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.27e-05	0.000442	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.19e-05	0.000427	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD8A—chronic obstructive pulmonary disease	2.19e-05	0.000427	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.14e-05	0.000417	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.12e-05	0.000412	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—IL6—chronic obstructive pulmonary disease	2.05e-05	0.000399	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—IL6—chronic obstructive pulmonary disease	2.04e-05	0.000398	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.04e-05	0.000398	CbGpPWpGaD
Amlexanox—FGF1—Immune System—ERBB3—chronic obstructive pulmonary disease	2.04e-05	0.000397	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.04e-05	0.000397	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL1B—chronic obstructive pulmonary disease	2.03e-05	0.000396	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.03e-05	0.000395	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.03e-05	0.000395	CbGpPWpGaD
Amlexanox—Headache—Prednisone—chronic obstructive pulmonary disease	2.02e-05	0.00612	CcSEcCtD
Amlexanox—IL3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.02e-05	0.000394	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.98e-05	0.000385	CbGpPWpGaD
Amlexanox—IL3—Immune System—EGFR—chronic obstructive pulmonary disease	1.93e-05	0.000377	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.93e-05	0.000376	CbGpPWpGaD
Amlexanox—Nausea—Prednisone—chronic obstructive pulmonary disease	1.92e-05	0.00581	CcSEcCtD
Amlexanox—FGF1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.89e-05	0.000368	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.88e-05	0.000367	CbGpPWpGaD
Amlexanox—FGF1—Disease—ERBB3—chronic obstructive pulmonary disease	1.88e-05	0.000367	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.88e-05	0.000366	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CRP—chronic obstructive pulmonary disease	1.86e-05	0.000363	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.86e-05	0.000361	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.84e-05	0.000359	CbGpPWpGaD
Amlexanox—FGF1—Immune System—TLR4—chronic obstructive pulmonary disease	1.79e-05	0.000348	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.78e-05	0.000346	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.77e-05	0.000346	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.77e-05	0.000344	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.76e-05	0.000342	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.74e-05	0.000339	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.71e-05	0.000333	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.69e-05	0.00033	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.68e-05	0.000327	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.65e-05	0.000321	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.63e-05	0.000317	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.62e-05	0.000316	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.61e-05	0.000315	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.6e-05	0.000313	CbGpPWpGaD
Amlexanox—FGF1—Disease—NOS2—chronic obstructive pulmonary disease	1.57e-05	0.000306	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.57e-05	0.000305	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.55e-05	0.000303	CbGpPWpGaD
Amlexanox—S100A12—Immune System—EGFR—chronic obstructive pulmonary disease	1.55e-05	0.000302	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.55e-05	0.000301	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.54e-05	0.000301	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.54e-05	0.000299	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.53e-05	0.000298	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—EGFR—chronic obstructive pulmonary disease	1.52e-05	0.000296	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL6—chronic obstructive pulmonary disease	1.49e-05	0.00029	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.47e-05	0.000286	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	1.46e-05	0.000284	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.45e-05	0.000282	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.44e-05	0.00028	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.42e-05	0.000277	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.41e-05	0.000275	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.39e-05	0.000271	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.37e-05	0.000266	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.36e-05	0.000265	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.36e-05	0.000264	CbGpPWpGaD
Amlexanox—FGF1—Disease—SERPINE1—chronic obstructive pulmonary disease	1.32e-05	0.000257	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.32e-05	0.000257	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.29e-05	0.000252	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.28e-05	0.000248	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.27e-05	0.000247	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.26e-05	0.000246	CbGpPWpGaD
Amlexanox—FGF1—Disease—NOS3—chronic obstructive pulmonary disease	1.26e-05	0.000246	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.25e-05	0.000244	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.24e-05	0.000241	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL6—chronic obstructive pulmonary disease	1.19e-05	0.000232	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.18e-05	0.00023	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.18e-05	0.00023	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—IL6—chronic obstructive pulmonary disease	1.17e-05	0.000228	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL1B—chronic obstructive pulmonary disease	1.16e-05	0.000226	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.13e-05	0.000219	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.12e-05	0.000219	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.1e-05	0.000214	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.08e-05	0.00021	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.07e-05	0.000209	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.05e-05	0.000205	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.04e-05	0.000203	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.04e-05	0.000203	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.02e-05	0.000199	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.92e-06	0.000193	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.91e-06	0.000193	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.61e-06	0.000187	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.54e-06	0.000186	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.47e-06	0.000185	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.25e-06	0.00018	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.08e-06	0.000177	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.07e-06	0.000177	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.9e-06	0.000173	CbGpPWpGaD
Amlexanox—FGF1—Immune System—EGFR—chronic obstructive pulmonary disease	8.86e-06	0.000173	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.83e-06	0.000172	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.63e-06	0.000168	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.63e-06	0.000168	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.4e-06	0.000164	CbGpPWpGaD
Amlexanox—FGF1—Disease—TGFB1—chronic obstructive pulmonary disease	8.34e-06	0.000162	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.21e-06	0.00016	CbGpPWpGaD
Amlexanox—FGF1—Disease—EGFR—chronic obstructive pulmonary disease	8.18e-06	0.000159	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.17e-06	0.000159	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.01e-06	0.000156	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.99e-06	0.000156	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.83e-06	0.000153	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.75e-06	0.000151	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.6e-06	0.000148	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.37e-06	0.000144	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.11e-06	0.000139	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.09e-06	0.000138	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.97e-06	0.000136	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.82e-06	0.000133	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL6—chronic obstructive pulmonary disease	6.81e-06	0.000133	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.77e-06	0.000132	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.72e-06	0.000131	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.64e-06	0.000129	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.36e-06	0.000124	CbGpPWpGaD
Amlexanox—FGF1—Disease—IL6—chronic obstructive pulmonary disease	6.28e-06	0.000122	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.26e-06	0.000122	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.16e-06	0.00012	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.14e-06	0.00012	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.85e-06	0.000114	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.84e-06	0.000114	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.73e-06	0.000112	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.57e-06	0.000109	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.36e-06	0.000104	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.16e-06	0.0001	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.1e-06	9.94e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.81e-06	9.37e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.72e-06	9.2e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.4e-06	8.57e-05	CbGpPWpGaD
